Dr. Alan Tan
Claim this profileRush University Medical Center
Area of expertise
Kidney Cancer
Alan Tan has run 6 trials for Kidney Cancer. Some of their research focus areas include:
Bladder Cancer
Alan Tan has run 5 trials for Bladder Cancer. Some of their research focus areas include:
Affiliated Hospitals
Rush University Medical Center
Vanderbilt University/Ingram Cancer Center
Clinical Trials Alan Tan is currently running
Immunotherapy + Targeted Therapy
for Genitourinary Cancers
This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the body. Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving cabozantinib, nivolumab, and ipilimumab may work better in treating patients with genitourinary tumors that have no treatment options compared to giving cabozantinib, nivolumab, or ipilimumab alone.
Recruiting
1 award
Phase 2
21 criteria
Immunotherapy With or Without Surgery
for Kidney Cancer
This phase III trial compares the effect of adding surgery to a standard of care immunotherapy-based drug combination versus a standard of care immunotherapy-based drug combination alone in treating patients with kidney cancer that has spread to other places in the body (metastatic). Immunotherapy with monoclonal antibodies, such as nivolumab, ipilimumab, pembrolizumab, and avelumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Axitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Surgery to remove the kidney, called a nephrectomy, is also considered standard of care; however, doctors who treat kidney cancer do not agree on its benefits. It is not yet known if the addition of surgery to an immunotherapy-based drug combination works better than an immunotherapy-based drug combination alone in treating patients with kidney cancer.
Recruiting
2 awards
Phase 3
16 criteria
More about Alan Tan
Clinical Trial Related
6 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Alan Tan has experience with
- Nivolumab
- Ipilimumab
- Pembrolizumab
- Avelumab
- Cabozantinib
- Axitinib
Breakdown of trials Alan Tan has run
Kidney Cancer
Bladder Cancer
Prostate Cancer
Renal Cell Carcinoma
Urothelial Bladder Cancer, Breast Cancer, Pancreatic Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alan Tan specialize in?
Alan Tan focuses on Kidney Cancer and Bladder Cancer. In particular, much of their work with Kidney Cancer has involved Stage IV patients, or patients who are TFEb positive.
Is Alan Tan currently recruiting for clinical trials?
Yes, Alan Tan is currently recruiting for 3 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Alan Tan has studied deeply?
Yes, Alan Tan has studied treatments such as Nivolumab, Ipilimumab, Pembrolizumab.
What is the best way to schedule an appointment with Alan Tan?
Apply for one of the trials that Alan Tan is conducting.
What is the office address of Alan Tan?
The office of Alan Tan is located at: Rush University Medical Center, Chicago, Illinois 60612 United States. This is the address for their practice at the Rush University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.